SCHEMBL7322658

SCHEMBL7322658

C[C@@H](OC1(c2cccs2)c2ccccc2-c2ccc(C(C)(C)C)cc21)[C@H](N)C(=O)O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 4/20 0.34
SLC1A2 P43004 3/20 0.34
SLC1A3 P43003 2/20 0.34
SLC1A1 P43005 2/20 0.34
NPC1 O15118 1/20 0.34
ALDH1A1 P00352 1/20 0.34
PLA2G1B P04054 1/20 0.34
NFKB1 P19838 1/20 0.34
CASP3 P42574 1/20 0.34
RAB9A P51151 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34
SENP8 Q96LD8 1/20 0.34
SENP7 Q9BQF6 1/20 0.34
SENP6 Q9GZR1 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
ATG4B Q9Y4P1 1/20 0.34
DNMT1 P26358 3/20 0.33
KIF11 P52732 2/20 0.32
TP53 P04637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7322653 1.00 PDK2 (0.34) PDK2SLC1A2SLC1A3SLC1A1NPC1
SCHEMBL7325924 0.89 SLC1A3 (0.41) PDK2SLC1A2SLC1A3SLC1A1ALDH1A1
SCHEMBL7325928 0.89 SLC1A3 (0.41) PDK2SLC1A2SLC1A3SLC1A1ALDH1A1
SCHEMBL7316689 0.87 KIF11 (0.36) PDK2SLC1A2SLC1A3SLC1A1ALDH1A1
SCHEMBL7316697 0.87 KIF11 (0.36) PDK2SLC1A2SLC1A3SLC1A1ALDH1A1
SCHEMBL7317186 0.87 NPC1 (0.37) PDK2SLC1A2NPC1ALDH1A1PLA2G1B
SCHEMBL7317182 0.87 NPC1 (0.37) PDK2SLC1A2NPC1ALDH1A1PLA2G1B
SCHEMBL7313467 0.86 PDK2 (0.36) PDK2SLC1A2SLC1A3SLC1A1
SCHEMBL7313476 0.86 PDK2 (0.36) PDK2SLC1A2SLC1A3SLC1A1
SCHEMBL7315669 0.85 PDK2 (0.39) PDK2SLC1A2SLC1A3SLC1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6162824-A NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS ALLELIX NEUROSCIENCE INC. 2000-12-19 US disclosed